Hutch News
Results per Page:
New Scientific Publications
Each week, Fred Hutch librarians search PubMed and Web of Science to discover new papers published by Fred Hutch authors
Week of January 23, 2022
Thwarting relapse in patients with acute myeloid leukemia
From the Hill Lab, Clinical Research Division
Send in the CARs: mesothelin-targeted CAR T cells against AML
From the Meshinchi Lab, Clinical Research Division, and Cancer Consortium colleagues
Two Fred Hutch postdocs named 2021 Damon Runyon Fellows
Awards to Drs. Edie Crosse and Ching-Ho Chang fund ‘creative, high-risk projects’ in cancer research
Taking aim: Mesothelin as a novel target for pediatric AML therapy
From the Meshinchi Lab, Clinical Research Division, and Cancer Consortium colleagues
Keep your enemies closer: targeting membrane-proximal domains for improved immunotherapy
From the Walter Lab, Clinical Research Division
Bridging the gap: bispecific proteins for targeted radiotherapy
From the Orozco Laboratory, Clinical Research Division
Timothy Ray Brown, who inspired millions living with HIV, dies of leukemia
For more than a decade after a stem cell transplant, he was the only person known to be cured of HIV/AIDS
New Brave Fellowship powers Dr. Alyssa Webster’s race for new leukemia cures
Running community funded new program to develop leaders in rare cancer research and advocates for diversity in science
Tip Sheet: Colorectal cancer, COVID-19 super-spreading, gene therapy for herpes, contagious cancer in Tasmanian devils – and more
Summaries of recent Fred Hutch research findings and other news with links for additional background and media contacts.
Experimental, precision strategy targets unique cancer protein found in certain acute myeloid leukemia cases
Lab study shows promise of aiming genetically engineered T-cell therapy at a gene fusion
Survival of cancer patients who did not meet standard trial eligibility
From the Percival Group, Public Health Sciences Division
$3.4 million grant to find safer, more effective leukemia treatments
New combinatorial targeted therapies before haploidentical bone marrow transplantation for AML could also help expand access to potential cures for underserved populations
99 problems when n=1?
In research, (sample) size matters
Gimme shelter: CRISPR hides healthy cells from leukemia drug
In mouse study, gene-edited cells stay safe as immunotherapy attacks cancer
WT1 T-cell Receptor Transduced T cells prevent AML relapse
From the Chapuis and Greenberg Labs, Clinical Research Division
Leukemia researcher Dr. Jerry Radich receives Kurt Enslein Endowed Chair
New chair continues legacy of giving sparked by lifesaving care
From Omaha to a Seattle lab, with 2 side trips to hell
Childhood AML survivor interns with the scientist who sequenced her genome
Immunotherapy prevents relapse in small leukemia trial
Engineered T cells kept leukemia from returning in 12 high-risk patients
The response is what counts
From the Othus Group, Public Health Sciences Division
5 questions with a cancer immunotherapy expert
Dr. Phil Greenberg to receive high honor for his contributions to the field